Utama › Kanser Prostat › Wisconsin › Milwaukee
Kajian klinikal Kanser Prostat di Milwaukee, WI
20 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar Milwaukee (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Mengambil pesertaFasa 3
- Ascension Columbia Saint Mary's Hospital-Milwaukee Campus, Milwaukee
- Medical College of Wisconsin, Milwaukee
- Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa, Wauwatosa · 5 mi jauh
- dan 6 lagi
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Mengambil pesertaFasa 3
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 mi jauh
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi jauh
- dan 1 lagi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- dan 9 lagi
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Mengambil pesertaFasa 2
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 mi jauh
- Froedtert Menomonee Falls Hospital, Menomonee Falls · 14 mi jauh
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- dan 7 lagi
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Mengambil pesertaFasa 3
- Medical College of Wisconsin ( Site 0020), Milwaukee
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Mengambil pesertaFasa 2/3
- Medical College Of Wisconsin, Milwaukee
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Mengambil pesertaFasa 3
- Medical College of Wisconsin, Milwaukee
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Mengambil pesertaFasa 3
- Medical College of Wisconsin ( Site 0008), Milwaukee
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Mengambil pesertaFasa 3
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Medical College of Wisconsin, Milwaukee
- dan 8 lagi
Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
Mengambil pesertaFasa 2
- Froedtert & the Medical College of Wisconsin, Milwaukee
The Vanguard Study: Testing a New Way to Screen for Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
- Zablocki Veterans Administration Medical Center, Milwaukee
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Mengambil pesertaFasa 1
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Mengambil peserta
- Froedtert Hospital, Milwaukee
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Mengambil pesertaFasa 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Mengambil pesertaFasa 1
- Medical College of Wisconsin, Milwaukee
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Mengambil pesertaFasa 2/3
- Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Mengambil pesertaKajian pemerhatian
- Medical College of Wisconsin, Milwaukee
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Milwaukee
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 3
- Medical College of Wisconsin, Milwaukee
- Zablocki Veterans Administration Medical Center, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 mi jauh
- dan 1 lagi
Kajian Kanser Prostat di bandar lain
- New York City, NY103 kajian
- Houston, TX76 kajian
- Los Angeles, CA61 kajian
- Boston, MA59 kajian
- St. Louis, MO46 kajian
- Chicago, IL45 kajian
- San Francisco, CA45 kajian
- Philadelphia, PA44 kajian
- Baltimore, MD43 kajian
- Nashville, TN42 kajian
- Seattle, WA42 kajian
- Washington, DC38 kajian
Kajian lain di Milwaukee
- Kanser Payudara23 kajian
- Kanser Paru-paru Bukan Sel Kecil22 kajian
- Kanser (semua jenis)22 kajian
- Kanser Paru-paru21 kajian
- Mieloma Pelbagai21 kajian
- Limfoma Folikular19 kajian
- Kanser Pankreas18 kajian
- Limfoma Bukan Hodgkin18 kajian
- Kanser Ovari17 kajian
- Leukemia Mieloid Akut17 kajian
- Limfoma Burkitt16 kajian
- Kegagalan Jantung16 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.